All In Biotech

Drug Trial Radar · NCT06420765

A Microneurography Study of NaV1.8 Inhibition in Healthy Adults

A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel Study Evaluating the Effects of Single Doses of NaV1.8 Inhibitors on C-Nociceptor Action Potentials in Healthy Adults

Last checked: Nov 19, 2026Latest source record: Apr 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

92

Actual

Start

May 21, 2024

Primary completion

Mar 22, 2025

Study completion Apr 4, 2025

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
May 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the effects of Nav1.8 inhibition on activity-dependent slowing (ADS) of C-nociceptor nerve fibers, evoked action potential (AP) conduction velocity of C-nociceptor nerve fibers using VX-150, VX-993 and VX-548.

Conditions

  • Pain

Interventions

  • VX-150Drug

    Suspension for oral administration.

  • VX-548Drug

    Solution or suspension for oral administration.

  • VX-993Drug

    Suspension for oral administration.

  • PlaceboDrug

    Suspension for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Activity Dependent Slowing (ADS) Over TimeTime frame: From Pre-dose up to 2-hours Post Dose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • MAC Clinical Research

    Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.